nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA5A—female reproductive system—uterine cancer	0.00693	0.138	CbGeAlD
Metolazone—CA7—renal system—uterine cancer	0.00575	0.114	CbGeAlD
Metolazone—SLC12A3—renal system—uterine cancer	0.00564	0.112	CbGeAlD
Metolazone—SLC12A3—female reproductive system—uterine cancer	0.00451	0.0896	CbGeAlD
Metolazone—CA9—female reproductive system—uterine cancer	0.00405	0.0803	CbGeAlD
Metolazone—CA12—renal system—uterine cancer	0.00374	0.0742	CbGeAlD
Metolazone—CA5B—mammalian vulva—uterine cancer	0.00314	0.0622	CbGeAlD
Metolazone—CA12—female reproductive system—uterine cancer	0.00299	0.0594	CbGeAlD
Metolazone—CA5B—female reproductive system—uterine cancer	0.00269	0.0533	CbGeAlD
Metolazone—Pain—Progesterone—uterine cancer	0.00263	0.00277	CcSEcCtD
Metolazone—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00261	0.00274	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.00268	CcSEcCtD
Metolazone—Feeling abnormal—Progesterone—uterine cancer	0.00254	0.00267	CcSEcCtD
Metolazone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00266	CcSEcCtD
Metolazone—Blood uric acid increased—Epirubicin—uterine cancer	0.00252	0.00265	CcSEcCtD
Metolazone—Gastrointestinal pain—Progesterone—uterine cancer	0.00252	0.00265	CcSEcCtD
Metolazone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00264	CcSEcCtD
Metolazone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.00261	CcSEcCtD
Metolazone—Ill-defined disorder—Dactinomycin—uterine cancer	0.00247	0.0026	CcSEcCtD
Metolazone—Hyperuricaemia—Doxorubicin—uterine cancer	0.00247	0.0026	CcSEcCtD
Metolazone—Nocturia—Doxorubicin—uterine cancer	0.00247	0.0026	CcSEcCtD
Metolazone—Anaemia—Dactinomycin—uterine cancer	0.00246	0.00259	CcSEcCtD
Metolazone—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00246	0.00259	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00245	0.00258	CcSEcCtD
Metolazone—Urticaria—Progesterone—uterine cancer	0.00245	0.00258	CcSEcCtD
Metolazone—Abdominal pain—Progesterone—uterine cancer	0.00243	0.00256	CcSEcCtD
Metolazone—CA5B—vagina—uterine cancer	0.00243	0.0482	CbGeAlD
Metolazone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00242	0.00255	CcSEcCtD
Metolazone—Neuropathy peripheral—Etoposide—uterine cancer	0.00242	0.00255	CcSEcCtD
Metolazone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00253	CcSEcCtD
Metolazone—Malaise—Dactinomycin—uterine cancer	0.0024	0.00253	CcSEcCtD
Metolazone—Leukopenia—Dactinomycin—uterine cancer	0.00239	0.00251	CcSEcCtD
Metolazone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.00251	CcSEcCtD
Metolazone—Skin exfoliation—Epirubicin—uterine cancer	0.00236	0.00249	CcSEcCtD
Metolazone—Blood urea increased—Epirubicin—uterine cancer	0.00234	0.00246	CcSEcCtD
Metolazone—Blood uric acid increased—Doxorubicin—uterine cancer	0.00233	0.00246	CcSEcCtD
Metolazone—Neuropathy—Epirubicin—uterine cancer	0.00232	0.00245	CcSEcCtD
Metolazone—CA4—renal system—uterine cancer	0.00231	0.0459	CbGeAlD
Metolazone—Agranulocytosis—Etoposide—uterine cancer	0.0023	0.00243	CcSEcCtD
Metolazone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00242	CcSEcCtD
Metolazone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.0024	CcSEcCtD
Metolazone—Hypersensitivity—Progesterone—uterine cancer	0.00227	0.00239	CcSEcCtD
Metolazone—Discomfort—Dactinomycin—uterine cancer	0.00224	0.00236	CcSEcCtD
Metolazone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00233	CcSEcCtD
Metolazone—Asthenia—Progesterone—uterine cancer	0.00221	0.00233	CcSEcCtD
Metolazone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00232	CcSEcCtD
Metolazone—Skin exfoliation—Doxorubicin—uterine cancer	0.00219	0.0023	CcSEcCtD
Metolazone—Pruritus—Progesterone—uterine cancer	0.00218	0.00229	CcSEcCtD
Metolazone—Blood urea increased—Doxorubicin—uterine cancer	0.00216	0.00228	CcSEcCtD
Metolazone—Neuropathy—Doxorubicin—uterine cancer	0.00215	0.00226	CcSEcCtD
Metolazone—Thrombocytopenia—Dactinomycin—uterine cancer	0.00213	0.00224	CcSEcCtD
Metolazone—Diarrhoea—Progesterone—uterine cancer	0.00211	0.00222	CcSEcCtD
Metolazone—Erythema multiforme—Etoposide—uterine cancer	0.0021	0.00221	CcSEcCtD
Metolazone—Anorexia—Dactinomycin—uterine cancer	0.00207	0.00218	CcSEcCtD
Metolazone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00216	CcSEcCtD
Metolazone—Photosensitivity—Epirubicin—uterine cancer	0.00205	0.00215	CcSEcCtD
Metolazone—Dizziness—Progesterone—uterine cancer	0.00204	0.00214	CcSEcCtD
Metolazone—Vascular purpura—Epirubicin—uterine cancer	0.00201	0.00211	CcSEcCtD
Metolazone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.002	0.00211	CcSEcCtD
Metolazone—Chills—Etoposide—uterine cancer	0.00199	0.00209	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00198	0.00209	CcSEcCtD
Metolazone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00208	CcSEcCtD
Metolazone—Vomiting—Progesterone—uterine cancer	0.00196	0.00206	CcSEcCtD
Metolazone—Rash—Progesterone—uterine cancer	0.00194	0.00204	CcSEcCtD
Metolazone—Dermatitis—Progesterone—uterine cancer	0.00194	0.00204	CcSEcCtD
Metolazone—Headache—Progesterone—uterine cancer	0.00193	0.00203	CcSEcCtD
Metolazone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00201	CcSEcCtD
Metolazone—Photosensitivity—Doxorubicin—uterine cancer	0.00189	0.00199	CcSEcCtD
Metolazone—Decreased appetite—Dactinomycin—uterine cancer	0.00189	0.00199	CcSEcCtD
Metolazone—Dysgeusia—Etoposide—uterine cancer	0.00189	0.00199	CcSEcCtD
Metolazone—Fatigue—Dactinomycin—uterine cancer	0.00188	0.00198	CcSEcCtD
Metolazone—Back pain—Etoposide—uterine cancer	0.00187	0.00197	CcSEcCtD
Metolazone—Purpura—Epirubicin—uterine cancer	0.00186	0.00196	CcSEcCtD
Metolazone—Pain—Dactinomycin—uterine cancer	0.00186	0.00196	CcSEcCtD
Metolazone—Vascular purpura—Doxorubicin—uterine cancer	0.00186	0.00196	CcSEcCtD
Metolazone—Muscle spasms—Etoposide—uterine cancer	0.00186	0.00195	CcSEcCtD
Metolazone—CA4—female reproductive system—uterine cancer	0.00185	0.0368	CbGeAlD
Metolazone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00194	CcSEcCtD
Metolazone—Lethargy—Epirubicin—uterine cancer	0.00183	0.00193	CcSEcCtD
Metolazone—Nausea—Progesterone—uterine cancer	0.00183	0.00193	CcSEcCtD
Metolazone—Hyponatraemia—Epirubicin—uterine cancer	0.0018	0.0019	CcSEcCtD
Metolazone—Feeling abnormal—Dactinomycin—uterine cancer	0.00179	0.00189	CcSEcCtD
Metolazone—Ill-defined disorder—Etoposide—uterine cancer	0.00179	0.00189	CcSEcCtD
Metolazone—Anaemia—Etoposide—uterine cancer	0.00178	0.00188	CcSEcCtD
Metolazone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00178	0.00187	CcSEcCtD
Metolazone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00187	CcSEcCtD
Metolazone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00185	CcSEcCtD
Metolazone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00185	CcSEcCtD
Metolazone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00184	CcSEcCtD
Metolazone—Malaise—Etoposide—uterine cancer	0.00174	0.00183	CcSEcCtD
Metolazone—Vertigo—Etoposide—uterine cancer	0.00173	0.00183	CcSEcCtD
Metolazone—Leukopenia—Etoposide—uterine cancer	0.00173	0.00182	CcSEcCtD
Metolazone—Purpura—Doxorubicin—uterine cancer	0.00172	0.00182	CcSEcCtD
Metolazone—Abdominal pain—Dactinomycin—uterine cancer	0.00172	0.00181	CcSEcCtD
Metolazone—Loss of consciousness—Etoposide—uterine cancer	0.0017	0.00179	CcSEcCtD
Metolazone—Lethargy—Doxorubicin—uterine cancer	0.0017	0.00179	CcSEcCtD
Metolazone—CA4—female gonad—uterine cancer	0.00169	0.0335	CbGeAlD
Metolazone—Cough—Etoposide—uterine cancer	0.00168	0.00177	CcSEcCtD
Metolazone—Hyponatraemia—Doxorubicin—uterine cancer	0.00167	0.00176	CcSEcCtD
Metolazone—Hypertension—Etoposide—uterine cancer	0.00167	0.00175	CcSEcCtD
Metolazone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00174	CcSEcCtD
Metolazone—Dry skin—Epirubicin—uterine cancer	0.00165	0.00173	CcSEcCtD
Metolazone—Chest pain—Etoposide—uterine cancer	0.00164	0.00173	CcSEcCtD
Metolazone—Orthostatic hypotension—Epirubicin—uterine cancer	0.00164	0.00173	CcSEcCtD
Metolazone—Hypokalaemia—Epirubicin—uterine cancer	0.00163	0.00172	CcSEcCtD
Metolazone—Discomfort—Etoposide—uterine cancer	0.00162	0.00171	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00162	0.0017	CcSEcCtD
Metolazone—Hypersensitivity—Dactinomycin—uterine cancer	0.0016	0.00169	CcSEcCtD
Metolazone—CA5B—lymph node—uterine cancer	0.00157	0.0312	CbGeAlD
Metolazone—Abdominal distension—Epirubicin—uterine cancer	0.00156	0.00165	CcSEcCtD
Metolazone—Asthenia—Dactinomycin—uterine cancer	0.00156	0.00164	CcSEcCtD
Metolazone—Thrombocytopenia—Etoposide—uterine cancer	0.00154	0.00162	CcSEcCtD
Metolazone—Dry skin—Doxorubicin—uterine cancer	0.00152	0.0016	CcSEcCtD
Metolazone—Pancreatitis—Epirubicin—uterine cancer	0.00152	0.0016	CcSEcCtD
Metolazone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00152	0.0016	CcSEcCtD
Metolazone—Hypokalaemia—Doxorubicin—uterine cancer	0.00151	0.00159	CcSEcCtD
Metolazone—Anorexia—Etoposide—uterine cancer	0.0015	0.00158	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.0015	0.00158	CcSEcCtD
Metolazone—Diarrhoea—Dactinomycin—uterine cancer	0.00149	0.00157	CcSEcCtD
Metolazone—Abdominal distension—Doxorubicin—uterine cancer	0.00145	0.00152	CcSEcCtD
Metolazone—Photosensitivity reaction—Epirubicin—uterine cancer	0.00142	0.00149	CcSEcCtD
Metolazone—Paraesthesia—Etoposide—uterine cancer	0.00141	0.00149	CcSEcCtD
Metolazone—Pancreatitis—Doxorubicin—uterine cancer	0.00141	0.00148	CcSEcCtD
Metolazone—Hyperglycaemia—Epirubicin—uterine cancer	0.0014	0.00147	CcSEcCtD
Metolazone—Somnolence—Etoposide—uterine cancer	0.0014	0.00147	CcSEcCtD
Metolazone—Drowsiness—Epirubicin—uterine cancer	0.00138	0.00146	CcSEcCtD
Metolazone—Vomiting—Dactinomycin—uterine cancer	0.00138	0.00146	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00137	0.00145	CcSEcCtD
Metolazone—Rash—Dactinomycin—uterine cancer	0.00137	0.00144	CcSEcCtD
Metolazone—Decreased appetite—Etoposide—uterine cancer	0.00137	0.00144	CcSEcCtD
Metolazone—Fatigue—Etoposide—uterine cancer	0.00136	0.00143	CcSEcCtD
Metolazone—Neuropathy peripheral—Epirubicin—uterine cancer	0.00136	0.00143	CcSEcCtD
Metolazone—Pain—Etoposide—uterine cancer	0.00135	0.00142	CcSEcCtD
Metolazone—Constipation—Etoposide—uterine cancer	0.00135	0.00142	CcSEcCtD
Metolazone—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00131	0.00138	CcSEcCtD
Metolazone—Epistaxis—Epirubicin—uterine cancer	0.00131	0.00137	CcSEcCtD
Metolazone—Feeling abnormal—Etoposide—uterine cancer	0.0013	0.00137	CcSEcCtD
Metolazone—Hyperglycaemia—Doxorubicin—uterine cancer	0.0013	0.00136	CcSEcCtD
Metolazone—Nausea—Dactinomycin—uterine cancer	0.00129	0.00136	CcSEcCtD
Metolazone—Agranulocytosis—Epirubicin—uterine cancer	0.00129	0.00136	CcSEcCtD
Metolazone—Gastrointestinal pain—Etoposide—uterine cancer	0.00129	0.00136	CcSEcCtD
Metolazone—Drowsiness—Doxorubicin—uterine cancer	0.00128	0.00135	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00127	0.00134	CcSEcCtD
Metolazone—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00126	0.00132	CcSEcCtD
Metolazone—Urticaria—Etoposide—uterine cancer	0.00125	0.00132	CcSEcCtD
Metolazone—Abdominal pain—Etoposide—uterine cancer	0.00124	0.00131	CcSEcCtD
Metolazone—Hepatitis—Epirubicin—uterine cancer	0.00124	0.00131	CcSEcCtD
Metolazone—Epistaxis—Doxorubicin—uterine cancer	0.00121	0.00127	CcSEcCtD
Metolazone—Agranulocytosis—Doxorubicin—uterine cancer	0.0012	0.00126	CcSEcCtD
Metolazone—Erythema multiforme—Epirubicin—uterine cancer	0.00117	0.00124	CcSEcCtD
Metolazone—Hypersensitivity—Etoposide—uterine cancer	0.00116	0.00122	CcSEcCtD
Metolazone—Tinnitus—Epirubicin—uterine cancer	0.00116	0.00122	CcSEcCtD
Metolazone—Hepatitis—Doxorubicin—uterine cancer	0.00115	0.00121	CcSEcCtD
Metolazone—Asthenia—Etoposide—uterine cancer	0.00113	0.00119	CcSEcCtD
Metolazone—Chills—Epirubicin—uterine cancer	0.00111	0.00117	CcSEcCtD
Metolazone—Pruritus—Etoposide—uterine cancer	0.00111	0.00117	CcSEcCtD
Metolazone—Erythema multiforme—Doxorubicin—uterine cancer	0.00109	0.00114	CcSEcCtD
Metolazone—CA4—lymph node—uterine cancer	0.00108	0.0215	CbGeAlD
Metolazone—Diarrhoea—Etoposide—uterine cancer	0.00108	0.00113	CcSEcCtD
Metolazone—Tinnitus—Doxorubicin—uterine cancer	0.00107	0.00113	CcSEcCtD
Metolazone—Flatulence—Epirubicin—uterine cancer	0.00107	0.00112	CcSEcCtD
Metolazone—Tension—Epirubicin—uterine cancer	0.00106	0.00112	CcSEcCtD
Metolazone—Dysgeusia—Epirubicin—uterine cancer	0.00106	0.00112	CcSEcCtD
Metolazone—Nervousness—Epirubicin—uterine cancer	0.00105	0.00111	CcSEcCtD
Metolazone—Back pain—Epirubicin—uterine cancer	0.00105	0.0011	CcSEcCtD
Metolazone—Dizziness—Etoposide—uterine cancer	0.00104	0.0011	CcSEcCtD
Metolazone—Muscle spasms—Epirubicin—uterine cancer	0.00104	0.0011	CcSEcCtD
Metolazone—Chills—Doxorubicin—uterine cancer	0.00103	0.00109	CcSEcCtD
Metolazone—Vision blurred—Epirubicin—uterine cancer	0.00102	0.00107	CcSEcCtD
Metolazone—Ill-defined disorder—Epirubicin—uterine cancer	0.001	0.00106	CcSEcCtD
Metolazone—Vomiting—Etoposide—uterine cancer	0.001	0.00105	CcSEcCtD
Metolazone—Anaemia—Epirubicin—uterine cancer	0.001	0.00105	CcSEcCtD
Metolazone—Agitation—Epirubicin—uterine cancer	0.000994	0.00105	CcSEcCtD
Metolazone—Rash—Etoposide—uterine cancer	0.000993	0.00105	CcSEcCtD
Metolazone—Dermatitis—Etoposide—uterine cancer	0.000992	0.00104	CcSEcCtD
Metolazone—Headache—Etoposide—uterine cancer	0.000987	0.00104	CcSEcCtD
Metolazone—Flatulence—Doxorubicin—uterine cancer	0.000986	0.00104	CcSEcCtD
Metolazone—Tension—Doxorubicin—uterine cancer	0.000982	0.00103	CcSEcCtD
Metolazone—Dysgeusia—Doxorubicin—uterine cancer	0.00098	0.00103	CcSEcCtD
Metolazone—Malaise—Epirubicin—uterine cancer	0.000975	0.00103	CcSEcCtD
Metolazone—Nervousness—Doxorubicin—uterine cancer	0.000972	0.00102	CcSEcCtD
Metolazone—Vertigo—Epirubicin—uterine cancer	0.000972	0.00102	CcSEcCtD
Metolazone—Syncope—Epirubicin—uterine cancer	0.00097	0.00102	CcSEcCtD
Metolazone—Leukopenia—Epirubicin—uterine cancer	0.000968	0.00102	CcSEcCtD
Metolazone—Back pain—Doxorubicin—uterine cancer	0.000968	0.00102	CcSEcCtD
Metolazone—Muscle spasms—Doxorubicin—uterine cancer	0.000962	0.00101	CcSEcCtD
Metolazone—Palpitations—Epirubicin—uterine cancer	0.000956	0.00101	CcSEcCtD
Metolazone—Loss of consciousness—Epirubicin—uterine cancer	0.000951	0.001	CcSEcCtD
Metolazone—Cough—Epirubicin—uterine cancer	0.000944	0.000994	CcSEcCtD
Metolazone—Vision blurred—Doxorubicin—uterine cancer	0.000943	0.000993	CcSEcCtD
Metolazone—Nausea—Etoposide—uterine cancer	0.000935	0.000985	CcSEcCtD
Metolazone—Hypertension—Epirubicin—uterine cancer	0.000934	0.000983	CcSEcCtD
Metolazone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000929	0.000978	CcSEcCtD
Metolazone—Anaemia—Doxorubicin—uterine cancer	0.000925	0.000974	CcSEcCtD
Metolazone—Arthralgia—Epirubicin—uterine cancer	0.000921	0.00097	CcSEcCtD
Metolazone—Chest pain—Epirubicin—uterine cancer	0.000921	0.00097	CcSEcCtD
Metolazone—Agitation—Doxorubicin—uterine cancer	0.00092	0.000969	CcSEcCtD
Metolazone—Anxiety—Epirubicin—uterine cancer	0.000918	0.000966	CcSEcCtD
Metolazone—Discomfort—Epirubicin—uterine cancer	0.00091	0.000958	CcSEcCtD
Metolazone—Malaise—Doxorubicin—uterine cancer	0.000903	0.00095	CcSEcCtD
Metolazone—Dry mouth—Epirubicin—uterine cancer	0.000901	0.000948	CcSEcCtD
Metolazone—Vertigo—Doxorubicin—uterine cancer	0.000899	0.000947	CcSEcCtD
Metolazone—Syncope—Doxorubicin—uterine cancer	0.000898	0.000945	CcSEcCtD
Metolazone—Leukopenia—Doxorubicin—uterine cancer	0.000896	0.000943	CcSEcCtD
Metolazone—Palpitations—Doxorubicin—uterine cancer	0.000884	0.000931	CcSEcCtD
Metolazone—Loss of consciousness—Doxorubicin—uterine cancer	0.00088	0.000926	CcSEcCtD
Metolazone—Cough—Doxorubicin—uterine cancer	0.000873	0.00092	CcSEcCtD
Metolazone—Shock—Epirubicin—uterine cancer	0.000868	0.000915	CcSEcCtD
Metolazone—Thrombocytopenia—Epirubicin—uterine cancer	0.000864	0.00091	CcSEcCtD
Metolazone—Hypertension—Doxorubicin—uterine cancer	0.000864	0.00091	CcSEcCtD
Metolazone—Chest pain—Doxorubicin—uterine cancer	0.000852	0.000897	CcSEcCtD
Metolazone—Arthralgia—Doxorubicin—uterine cancer	0.000852	0.000897	CcSEcCtD
Metolazone—Anxiety—Doxorubicin—uterine cancer	0.000849	0.000894	CcSEcCtD
Metolazone—Discomfort—Doxorubicin—uterine cancer	0.000842	0.000887	CcSEcCtD
Metolazone—Anorexia—Epirubicin—uterine cancer	0.000841	0.000886	CcSEcCtD
Metolazone—Dry mouth—Doxorubicin—uterine cancer	0.000833	0.000878	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000804	0.000847	CcSEcCtD
Metolazone—Shock—Doxorubicin—uterine cancer	0.000804	0.000846	CcSEcCtD
Metolazone—Thrombocytopenia—Doxorubicin—uterine cancer	0.0008	0.000842	CcSEcCtD
Metolazone—Insomnia—Epirubicin—uterine cancer	0.000798	0.000841	CcSEcCtD
Metolazone—Paraesthesia—Epirubicin—uterine cancer	0.000793	0.000835	CcSEcCtD
Metolazone—Somnolence—Epirubicin—uterine cancer	0.000785	0.000826	CcSEcCtD
Metolazone—Anorexia—Doxorubicin—uterine cancer	0.000779	0.00082	CcSEcCtD
Metolazone—Dyspepsia—Epirubicin—uterine cancer	0.000777	0.000818	CcSEcCtD
Metolazone—Decreased appetite—Epirubicin—uterine cancer	0.000767	0.000808	CcSEcCtD
Metolazone—Fatigue—Epirubicin—uterine cancer	0.000761	0.000801	CcSEcCtD
Metolazone—Constipation—Epirubicin—uterine cancer	0.000755	0.000795	CcSEcCtD
Metolazone—Pain—Epirubicin—uterine cancer	0.000755	0.000795	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000744	0.000784	CcSEcCtD
Metolazone—Insomnia—Doxorubicin—uterine cancer	0.000739	0.000778	CcSEcCtD
Metolazone—Paraesthesia—Doxorubicin—uterine cancer	0.000733	0.000772	CcSEcCtD
Metolazone—Feeling abnormal—Epirubicin—uterine cancer	0.000727	0.000766	CcSEcCtD
Metolazone—Somnolence—Doxorubicin—uterine cancer	0.000726	0.000765	CcSEcCtD
Metolazone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000722	0.00076	CcSEcCtD
Metolazone—Dyspepsia—Doxorubicin—uterine cancer	0.000719	0.000757	CcSEcCtD
Metolazone—Decreased appetite—Doxorubicin—uterine cancer	0.00071	0.000748	CcSEcCtD
Metolazone—Fatigue—Doxorubicin—uterine cancer	0.000704	0.000742	CcSEcCtD
Metolazone—Urticaria—Epirubicin—uterine cancer	0.000701	0.000738	CcSEcCtD
Metolazone—Constipation—Doxorubicin—uterine cancer	0.000698	0.000736	CcSEcCtD
Metolazone—Pain—Doxorubicin—uterine cancer	0.000698	0.000736	CcSEcCtD
Metolazone—Abdominal pain—Epirubicin—uterine cancer	0.000698	0.000735	CcSEcCtD
Metolazone—Feeling abnormal—Doxorubicin—uterine cancer	0.000673	0.000709	CcSEcCtD
Metolazone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000668	0.000703	CcSEcCtD
Metolazone—Hypersensitivity—Epirubicin—uterine cancer	0.00065	0.000685	CcSEcCtD
Metolazone—Urticaria—Doxorubicin—uterine cancer	0.000649	0.000683	CcSEcCtD
Metolazone—Abdominal pain—Doxorubicin—uterine cancer	0.000646	0.00068	CcSEcCtD
Metolazone—Asthenia—Epirubicin—uterine cancer	0.000633	0.000667	CcSEcCtD
Metolazone—Pruritus—Epirubicin—uterine cancer	0.000625	0.000658	CcSEcCtD
Metolazone—Diarrhoea—Epirubicin—uterine cancer	0.000604	0.000636	CcSEcCtD
Metolazone—Hypersensitivity—Doxorubicin—uterine cancer	0.000602	0.000634	CcSEcCtD
Metolazone—Asthenia—Doxorubicin—uterine cancer	0.000586	0.000617	CcSEcCtD
Metolazone—Dizziness—Epirubicin—uterine cancer	0.000584	0.000615	CcSEcCtD
Metolazone—Pruritus—Doxorubicin—uterine cancer	0.000578	0.000609	CcSEcCtD
Metolazone—Vomiting—Epirubicin—uterine cancer	0.000561	0.000591	CcSEcCtD
Metolazone—Diarrhoea—Doxorubicin—uterine cancer	0.000559	0.000589	CcSEcCtD
Metolazone—Rash—Epirubicin—uterine cancer	0.000557	0.000586	CcSEcCtD
Metolazone—Dermatitis—Epirubicin—uterine cancer	0.000556	0.000586	CcSEcCtD
Metolazone—Headache—Epirubicin—uterine cancer	0.000553	0.000582	CcSEcCtD
Metolazone—Dizziness—Doxorubicin—uterine cancer	0.00054	0.000569	CcSEcCtD
Metolazone—Nausea—Epirubicin—uterine cancer	0.000524	0.000552	CcSEcCtD
Metolazone—Vomiting—Doxorubicin—uterine cancer	0.000519	0.000547	CcSEcCtD
Metolazone—Rash—Doxorubicin—uterine cancer	0.000515	0.000542	CcSEcCtD
Metolazone—Dermatitis—Doxorubicin—uterine cancer	0.000515	0.000542	CcSEcCtD
Metolazone—Headache—Doxorubicin—uterine cancer	0.000512	0.000539	CcSEcCtD
Metolazone—Nausea—Doxorubicin—uterine cancer	0.000485	0.000511	CcSEcCtD
